VBI Vaccines (VBIV)
NASDAQ:VBIV
Holding VBIV?
Track your performance easily

VBI Vaccines (VBIV) Stock Forecast & Price Target

2,222 Followers
See the Price Targets and Ratings of:

VBIV Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
VBI
Vaccines
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

VBIV Stock 12 Month Forecast

There Are No Analyst Ratings for VBIV In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

VBIV Financial Forecast

VBIV Earnings Forecast

Next quarter’s earnings estimate for VBIV is -$0.32 with a range of -$0.32 to -$0.32. The previous quarter’s EPS was ―. VBIV beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.30% of the time in the same period. In the last calendar year VBIV has Underperformed its overall industry.
Next quarter’s earnings estimate for VBIV is -$0.32 with a range of -$0.32 to -$0.32. The previous quarter’s EPS was ―. VBIV beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.30% of the time in the same period. In the last calendar year VBIV has Underperformed its overall industry.

VBIV Sales Forecast

Next quarter’s sales forecast for VBIV is $3.19M with a range of $3.19M to $3.19M. The previous quarter’s sales results were ―. VBIV beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.68% of the time in the same period. In the last calendar year VBIV has Underperformed its overall industry.
Next quarter’s sales forecast for VBIV is $3.19M with a range of $3.19M to $3.19M. The previous quarter’s sales results were ―. VBIV beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.68% of the time in the same period. In the last calendar year VBIV has Underperformed its overall industry.

VBIV Analyst Recommendation Trends

Rating
Aug 22
Nov 22
Feb 23
Apr 23
Jul 23
Strong Buy
2
3
2
2
2
Buy
1
0
1
1
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
In the current month, VBIV has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. VBIV average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

VBIV Stock Forecast FAQ

What is VBIV’s average 12-month price target, according to analysts?
Currently, no data Available
What is VBIV’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for VBIV, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is VBIV a Buy, Sell or Hold?
      Currently, no data Available
      What is VBI Vaccines’s price target?
      Currently, no data Available
      What do analysts say about VBI Vaccines?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of VBIV?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis